Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 969040, 7 pages
http://dx.doi.org/10.1155/2015/969040
Review Article

Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review

1Department of Sciences for Health Promotion and Mother-Child Care “G. D’Alessandro”, University of Palermo, Via del Vespro 127, 90127 Palermo, Italy
2Biomedical Department of Internal Medicine and Specialities, University of Palermo, Via del Vespro 141, 90127 Palermo, Italy

Received 11 October 2014; Revised 23 January 2015; Accepted 10 February 2015

Academic Editor: Ling-Qing Yuan

Copyright © 2015 Paola Di Carlo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Langsetmo, C. Berger, N. Kreiger et al., “Calcium and Vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos),” Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 7, pp. 3010–3018, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. V. A. Moyer, “Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive services Task Force recommendation statement,” Annals of Internal Medicine, vol. 160, no. 8, pp. 558–564, 2014. View at Publisher · View at Google Scholar
  3. D. A. Hanley, A. Cranney, G. Jones et al., “Guidelines committee of the scientific advisory council of osteoporosis canada,” Canadian Medical Association Journal, vol. 182, no. 12, pp. E610–E618, 2010. View at Google Scholar
  4. M. Hewison, “Vitamin D and immune function: an overview,” Proceedings of the Nutrition Society, vol. 71, no. 1, pp. 50–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Roy, K. Shrinivas, and B. Bagchi, “A stochastic chemical dynamic approach to correlate autoimmunity and optimal vitamin-D range,” PLoS ONE, vol. 9, no. 6, Article ID e100635, 2014. View at Publisher · View at Google Scholar
  6. P. E. Pfeffer, E. H. Mann, E. Hornsby et al., “Vitamin D influences asthmatic pathology through its action on diverse immunological pathways,” Annals of the American Thoracic Society, vol. 11, supplement 5, pp. S314–S321, 2014. View at Publisher · View at Google Scholar
  7. P. Iruzubieta, Á. Terán, J. Crespo, and E. Fábrega, “Vitamin D deficiency in chronic liver disease,” World Journal of Hepatology, vol. 6, no. 12, pp. 901–915, 2014. View at Publisher · View at Google Scholar
  8. Y.-Q. Luo, X.-X. Wu, Z.-X. Ling, Y.-W. Cheng, L. Yuan, and C. Xiang, “Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis,” Journal of Zhejiang University SCIENCE B, vol. 15, no. 10, pp. 900–906, 2014. View at Publisher · View at Google Scholar
  9. S. Petta, S. Grimaudo, V. D. Marco et al., “Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients,” Journal of Viral Hepatitis, vol. 20, no. 7, pp. 486–493, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Terrier, F. Carrat, G. Geri et al., “Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis,” Journal of Hepatology, vol. 55, no. 4, pp. 756–761, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Abu-Mouch, Z. Fireman, J. Jarchovsky, A.-R. Zeina, and N. Assy, “Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients,” World Journal of Gastroenterology, vol. 17, no. 47, pp. 5184–5190, 2011. View at Google Scholar · View at Scopus
  12. S. Petta, S. Grimaudo, C. Tripodo et al., “The hepatic expression of vitamin d receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 1, pp. 193–200, 2015. View at Publisher · View at Google Scholar
  13. M. Gal-Tanamy, L. Bachmetov, A. Ravid et al., “Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes,” Hepatology, vol. 54, no. 5, pp. 1570–1579, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Bitetto, C. Fabris, E. Fornasiere et al., “Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C,” Transplant International, vol. 24, no. 1, pp. 43–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. K. Rockstroh, A. Mocroft, V. Soriano et al., “Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy,” Journal of Infectious Diseases, vol. 192, no. 6, pp. 992–1002, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. E. Sherman, S. D. Rouster, R. T. Chung, and N. Rajicic, “Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group,” Clinical Infectious Diseases, vol. 34, no. 6, pp. 831–837, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. C. T. Staples Jr., D. Rimland, and D. Dudas, “Hepatitis C in the HIV (Human Immunodeficiency Virus) Atlanta V.A. (Veterans Affairs Medical Center) cohort study (HAVACS): the effect of coinfection on survival,” Clinical Infectious Diseases, vol. 29, no. 1, pp. 150–154, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Bonjoch, M. Figueras, C. Estany et al., “Osteoporosis Study Group. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohortstudy,” AIDS, vol. 24, no. 18, pp. 2827–2833, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. V. A. Triant, T. T. Brown, H. Lee, and S. K. Grinspoon, “Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 9, pp. 3499–3504, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. F. Luetkemeyer, D. V. Havlir, and J. S. Currier, “CROI 2013: complications of HIV disease, viral hepatitis, and antiretroviral therapy,” Topics in Antiviral Medicine, vol. 21, no. 2, pp. 62–74, 2013. View at Google Scholar · View at Scopus
  21. N. M. Maalouf, S. Zhang, H. Drechsler, G. R. Brown, P. Tebas, and R. Bedimo, “Hepatitis C Co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients,” Journal of Bone and Mineral Research, vol. 28, no. 12, pp. 2577–2583, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. H. V. Dong, Y. I. Cortés, S. Shiau, and M. T. Yin, “Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis,” AIDS, vol. 28, no. 14, pp. 2119–2131, 2014. View at Google Scholar
  23. C. Zhou, M. Assem, J. C. Tay et al., “Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia,” The Journal of Clinical Investigation, vol. 116, no. 6, pp. 1703–1712, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al., “Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline,” The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 1911–1930, 2011. View at Google Scholar
  25. E. Ramayo, M. P. González-Moreno, J. Macías et al., “Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy,” AIDS Research and Human Retroviruses, vol. 21, no. 11, pp. 915–921, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Gyllensten, F. Josephson, K. Lidman, and M. Sääf, “Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59 degrees,” AIDS, vol. 20, no. 14, pp. 1906–1907, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Childs, C. Kadish, W. Branch-Elliman, S. Fishman, M. Mullen, and A. Branch, “Vitamin D and calcium supplements reverse the secondary hyperparathyroidism that commonly occurs in HIV patients on TDF containing HAART,” in Proceedings of the 15th Annual Conference of the British HIV Association, vol. 10, p. 40, HIV Medication, Liverpool, UK, 2009, Abstract P89.
  28. P. Rivas, M. Górgolas, R. García-Delgado, M. Díaz-Curiel, A. Goyenechea, and M. L. Fernández-Guerrero, “Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavir,” HIV Medicine, vol. 9, no. 2, pp. 89–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. P. L. Havens, K. Mulligan, R. Hazra et al., “Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 11, pp. 4004–4013, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. V. W. Harris and T. T. Brown, “Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies,” The Journal of Infectious Diseases, vol. 205, no. 3, pp. S391–S398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Guzmán-Fulgencio, M. García-Álvarez, J. Berenguer et al., “Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients,” Journal of Infection, vol. 68, no. 2, pp. 176–184, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Avihingsanon, S. Jitmitraparp, P. Tangkijvanich et al., “Advanced liver fibrosis by transient elastography, Fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels,” Journal of Gastroenterology and Hepatology, vol. 29, no. 9, pp. 1706–1714, 2014. View at Publisher · View at Google Scholar
  33. D. El-Maouche, S. H. Mehta, C. G. Sutcliffe et al., “Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV–HCV coinfection,” Antiviral Therapy, vol. 18, no. 2, pp. 237–242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Mandorfer, B. A. Payer, P. Schwabl et al., “Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3,” Liver International, vol. 35, no. 3, pp. 876–885, 2015. View at Publisher · View at Google Scholar
  35. M. Mandorfer, T. Reiberger, B. A. Payer et al., “Low vitamin D levels are associated with impaired virologic response to PEGIFN+RBV therapy in HIV-hepatitis C virus coinfected patients,” AIDS, vol. 27, no. 2, pp. 227–232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. A. D. Branch, M. Kang, K. Hollabaugh, C. M. Wyatt, R. T. Chung, and M. J. Glesby, “In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use,” The American Journal of Clinical Nutrition, vol. 98, no. 2, pp. 423–429, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Linari, G. Montorzi, D. Bartolozzi et al., “Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients,” Haemophilia, vol. 19, no. 1, pp. 126–133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. V. L. Vecchi, M. Soresi, L. Giannitrapani et al., “Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects,” BMC Infectious Diseases, vol. 12, article 192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Milazzo, C. Mazzali, G. Bestetti et al., “Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population,” Current HIV Research, vol. 9, no. 3, pp. 186–193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al., “Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, pp. 1153–1158, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Cosman, D. C. Morgan, J. W. Nieves et al., “Resistance to bone resorbing effects of PTH in black women,” Journal of Bone and Mineral Research, vol. 12, no. 6, pp. 958–966, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. G. B. Taksler, D. M. Cutler, E. Giovannucci, and N. L. Keating, “Vitamin D deficiency in minority populations,” Public Health Nutrition, vol. 15, pp. 1–13, 2014. View at Google Scholar
  43. P. Pludowski, W. B. Grant, H. P. Bhattoa et al., “Vitamin D status in central Europe,” International Journal of Endocrinology, vol. 2014, Article ID 589587, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. M. F. Holick and C. M. Gordon, “The hormone foundation's: patient guide to vitamin D deficiency,” The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. 1–2, 2011. View at Google Scholar · View at Scopus
  45. J. F. Calderon-Garcia, J. M. Moran, R. Roncero-Martin, P. Rey-Sanchez, F. J. Rodriguez-Velasco, and J. D. Pedrera-Zamorano, “Dietary habits, nutrients and bone mass in Spanish premenopausal women: the contribution of fish to better bone health,” Nutrients, vol. 5, no. 1, pp. 10–22, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Costa Silva, T. Erotides Silva, M. L. Alentar et al., “Factors associated with 25-hydroxyvitamin D levels in patients with liver cirrhosis,” Annals of Hepatology, vol. 14, no. 1, pp. 99–107, 2015. View at Google Scholar
  47. J. L. González-Calvin, J. L. Mundi, F. J. Casado-Caballero, A. C. Abadia, and J. J. Martin-Ibañez, “Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 12, pp. 4844–4850, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. M. P. Björkman, A. J. Sorva, J. Risteli, and R. S. Tilvis, “Low parathyroid hormone levels in bedridden geriatric patients with vitamin D deficiency,” Journal of the American Geriatrics Society, vol. 57, no. 6, pp. 1045–1050, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. V. A. Stallings, J. I. Schall, M. L. Hediger et al., “High-dose vitamin D3 supplementation in children and young adults with HIV: a randomized, placebo-controlled trial,” The Pediatric Infectious Disease Journal. In press.